Roy Hartvig Larsen
Chief Executive Officer chez Sciencons AS
Fortune : 199 920 $ au 31/03/2024
Profil
Roy Hartvig Larsen is the founder of Artbio, Inc. (founded in 2021), Algeta ASA (founded in 1997), Nordic Nanovector ASA (founded in 2009), and Oncoinvent AS (founded in 2010).
He held the title of Chief Scientific Officer at Algeta ASA in 2006, Independent Director at Nordic Nanovector ASA from 2015 to 2016, and Chairman at Oncoinvent AS from 2010 to 2024.
Dr. Larsen is also the founder of Sciencons AS.
He has former job experience as Chairman at Artbio AS and Managing Director at Sciencons Ltd.
Dr. Larsen obtained a doctorate degree from Duke University and the University of Oslo.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
THOR MEDICAL ASA
0,86% | 31/07/2023 | 2 008 435 ( 0,86% ) | 199 920 $ | 31/03/2024 |
Postes actifs de Roy Hartvig Larsen
| Sociétés | Poste | Début |
|---|---|---|
Sciencons AS
 Sciencons AS Financial ConglomeratesFinance Sciencons AS is an investment company that focuses on research and development businesses. The company was founded on January 2, 2014 and is headquartered in Oslo, Norway. | Chief Executive Officer | - |
Anciens postes connus de Roy Hartvig Larsen
| Sociétés | Poste | Fin |
|---|---|---|
Oncoinvent AS
 Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | Founder | 02/04/2024 |
| THOR MEDICAL | Founder | 19/05/2016 |
| ALGETA ASA | Founder | 01/01/2006 |
Artbio, Inc.
 Artbio, Inc. Hospital/Nursing ManagementHealth Services Artbio, Inc. is a company that is focused on redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building an ecosystem that maximizes their potential. Artbio is based in Cambridge, MA and has subsidiaries in Norway. The company puts the patient at the core of everything they do. The company was founded in 2021 by Emanuele Ostuni, Roy Hartvig Larsen, and Øyvind Sverre Bruland. Emanuele Ostuni has been the CEO since 2021. | Founder | - |
Artbio AS
 Artbio AS BiotechnologyHealth Technology Part of Artbio, Inc., Artbio AS is a clinical-stage radiopharmaceutical biotechnology business that works to create a new class of alpha radio ligand medicines. The private company is based in Oslo, Norway. The Norwegian company was founded in 2018. The CEO is Emanuele Ostuni. | Chairman | - |
Formation de Roy Hartvig Larsen
| Duke University | Doctorate Degree |
| University of Oslo | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Sciencons Ltd.
 Sciencons Ltd. MiscellaneousMiscellaneous Sciencons Ltd. operated as a dormant company. The company was founded by Roy Hartvig Larsen on November 7, 2006 and was headquartered in London, the United Kingdom. | Miscellaneous |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | Health Technology |
Artbio AS
Artbio AS BiotechnologyHealth Technology Part of Artbio, Inc., Artbio AS is a clinical-stage radiopharmaceutical biotechnology business that works to create a new class of alpha radio ligand medicines. The private company is based in Oslo, Norway. The Norwegian company was founded in 2018. The CEO is Emanuele Ostuni. | Health Technology |
Artbio, Inc.
Artbio, Inc. Hospital/Nursing ManagementHealth Services Artbio, Inc. is a company that is focused on redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building an ecosystem that maximizes their potential. Artbio is based in Cambridge, MA and has subsidiaries in Norway. The company puts the patient at the core of everything they do. The company was founded in 2021 by Emanuele Ostuni, Roy Hartvig Larsen, and Øyvind Sverre Bruland. Emanuele Ostuni has been the CEO since 2021. | Health Services |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
Sciencons AS
Sciencons AS Financial ConglomeratesFinance Sciencons AS is an investment company that focuses on research and development businesses. The company was founded on January 2, 2014 and is headquartered in Oslo, Norway. | Finance |
